Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 22911697)


Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM; INSIGHT SMART Study Group; ESPRIT Study Group.

PLoS One. 2012;7(7):e40245. Epub 2012 Jul 20.


Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.

Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.

AIDS. 2012 Sep 24;26(15):1917-26.


Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.

Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ.

Am J Kidney Dis. 2010 Jul;56(1):23-31. doi: 10.1053/j.ajkd.2010.01.015. Epub 2010 Apr 18.


Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA.

J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373. Epub 2013 Jul 31.


Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.


Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2013 Jun;19(6):619-26. doi: 10.1002/lt.23648.


High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH.

PLoS One. 2013 May 22;8(5):e63303. doi: 10.1371/journal.pone.0063303. Print 2013.


Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM.

AIDS. 2012 Sep 24;26(15):1907-15.


Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.

Mederacke I, Meier M, Lüth JB, Schmidt-Gürtler H, Raupach R, Horn-Wichmann R, Wursthorn K, Potthoff A, Colucci G, Manns MP, Wedemeyer H, Tillmann HL.

Nephrol Dial Transplant. 2011 Aug;26(8):2648-56. doi: 10.1093/ndt/gfq757. Epub 2011 Jan 27.


Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.

Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A; EuroSIDA in EuroCoord.

HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16.


Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.

Gillis J, Cooper C, Rourke S, Rueda S, O'Brien K, Collins E, Rachlis A, Hart TA, Raboud J; OHTN Cohort Study Group.

Qual Life Res. 2013 Sep;22(7):1525-35. doi: 10.1007/s11136-012-0283-7. Epub 2012 Oct 17.


Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.

Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, Sagnelli C, Filippini A, Sagnelli E.

J Med Virol. 2007 Nov;79(11):1679-85.


Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.

Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L.

Am J Kidney Dis. 2009 Jul;54(1):43-50. doi: 10.1053/j.ajkd.2009.02.009. Epub 2009 Apr 25.


High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.

Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.

HIV Med. 2010 Jan;11(1):85-9. doi: 10.1111/j.1468-1293.2009.00742.x. Epub 2009 Jul 29.


Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.


Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.

Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.

J Viral Hepat. 2010 Jan;17(1):65-76. doi: 10.1111/j.1365-2893.2009.01153.x. Epub 2009 Aug 4.


Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.

Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.

J Med Virol. 2012 Jun;84(6):857-65. doi: 10.1002/jmv.23293.


Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.

Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM; TREAT Asia HIV Observational Database.

J Gastroenterol Hepatol. 2007 Sep;22(9):1510-8. Epub 2007 Jul 20.


Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.

Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF; Infectious Disease Clinical Research Program HIV/STI Working Group.

HIV Med. 2013 Feb;14(2):65-76. doi: 10.1111/j.1468-1293.2012.01036.x. Epub 2012 Jul 19.


Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk